Philip A Kelly
Overview
Explore the profile of Philip A Kelly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Logan Ellis H, Al-Agil M, Kelly P, Teo J, Sharpe C, Whyte M
Clin Exp Med
. 2024 Dec;
25(1):16.
PMID: 39708241
Background: Inhibitors of the renin-angiotensin-aldosterone system (RAAS), such as ACE inhibitors (ACEi), angiotensin-II receptor blockers and mineralocorticoid receptor antagonists, reduce morbidity and mortality in hypertension, congestive heart failure and chronic...
2.
Logan Ellis H, Al-Agil M, Kelly P, Teo J, Sharpe C, Whyte M
Clin Exp Med
. 2024 Aug;
24(1):190.
PMID: 39136879
Hyperkalaemia is associated with prolonged hospital admission and worse mortality. Hyperkalaemia may also necessitate clinical consults, therapies for hyperkalaemia and high-dependency bed utilisation. We evaluated the 'hidden' human and organisational...
3.
Jervis M, Mitchell A, Islam N, Mustafa O, Kelly P, Whyte M
Diabetes Metab Res Rev
. 2022 Sep;
38(8):e3574.
PMID: 36052434
Introduction: Glycaemic control associates with better outcomes for hospitalised patients. Whether GLP-1 receptor agonists (GLP-1 RA) are suitable and effective drugs for inpatients is unclear. Methods: A retrospective, single centre,...
4.
Whyte M, Kelly P
Future Healthc J
. 2022 Aug;
9(2):188-189.
PMID: 35928189
The electronic health record has dramatically improved the safety of medical care as well as the clarity and accessibility of the notes. An equally profound, but under-recognised consequence, is the...
5.
Whyte M, Kelly P
J R Coll Physicians Edinb
. 2021 Apr;
51(1):106-110.
PMID: 33877154
No abstract available.
6.
Foley R, Ramachandran S, Akintimehin A, Williams S, Connor S, Hart J, et al.
Clin Med (Lond)
. 2021 Mar;
21(2):96-100.
PMID: 33762366
Background: The Ottawa subarachnoid haemorrhage (SAH) rule and the Emerald SAH rule are clinical decision tools to aid in the decision for computed tomography (CT) of the head in patients...
7.
Whyte M, Barker R, Kelly P, Gonzalez E, Czuprynska J, Patel R, et al.
Thromb Res
. 2021 Mar;
201:113-115.
PMID: 33662797
No abstract available.
8.
Nanzer A, dAncona G, Kelly P, Jackson D
Eur Respir J
. 2020 Aug;
56(2).
PMID: 32763964
No abstract available.
9.
Whyte M, Kelly P, Gonzalez E, Arya R, Roberts L
Thromb Res
. 2020 Jul;
195:95-99.
PMID: 32682004
Background: Coronavirus disease 2019 (COVID-19) is characterised by dyspnoea and abnormal coagulation parameters, including raised D-dimer. Data suggests a high incidence of pulmonary embolism (PE) in ventilated patients with COVID-19....
10.
Nanzer A, Chowdhury A, Raheem A, Roxas C, Fernandes M, Thomson L, et al.
Eur Respir J
. 2020 Mar;
56(1).
PMID: 32217655
No abstract available.